(1)With regard to the selling of Kapa SA to Kapa US for some US$4 million in 2015, which was later sold to Roche in Switzerland for some US$450 million, (a)(i) who negotiated the selling price on behalf of the Technology Innovation Agency and (ii) how were they qualified to do so, (b) how was the selling value calculated at that stage, (c) on what legal grounds is the transaction challenged at present and (d) what is the reason that arbitration was selected as the method for settling the case;
(2) whether the report commissioned by his predecessor, Dr G N M Pandor, had been completed; if not, why not; if so, (a) is it available and (b) will his department make the specified report public?